ENTRADA THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$377M
↓-28.3% -$149Mvs FY2024
Total Liabilities
$71M
↓-27.0% -$26Mvs FY2024
Equity
$306M
↓-28.6% -$123Mvs FY2024
Cash
$90M
↓-10.7% -$11Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $377M | $526M |
| Current Assets | $306M | $440M |
| Cash | $90M | $101M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $216M | $339M |
| Non-Current Assets | $71M | $86M |
| PPE | $7M | $11M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $64M | $75M |
| Total Liab+Eq | $377M | $526M |
| Current Liab. | $24M | $39M |
| Accounts Payable | $2M | $4M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $342K | $14M |
| Other CL | $22M | $22M |
| Non-Current Liab. | $47M | $58M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $47M | $58M |
| Equity | $306M | $429M |
| Retained Earnings | $273M | $129M |
| Other Equity | $33M | $299M |
QuarterCharts · SEC EDGAR data · TRDA · Comparing FY2025 vs FY2024